Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru

Percy Soto-Becerra, Carlos Culquichicón, Yamilee Hurtado-Roca, Roger V. Araujo-Castillo
doi: https://doi.org/10.1101/2020.10.06.20208066

Article Information

doi 
https://doi.org/10.1101/2020.10.06.20208066
History 
  • October 8, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Percy Soto-Becerra1,
  2. Carlos Culquichicón1,
  3. Yamilee Hurtado-Roca1 and
  4. Roger V. Araujo-Castillo1,*
  1. 1Instituto de Evaluación de Tecnologías en Salud e Investigación – IETSI, EsSalud, Lima, Peru
  1. ↵*Corresponding author: Roger V. Araujo-Castillo, Av. Arenales 1302, office 310. Jesus Maria, Lima 15073, Peru., Phone: 51(1) 265-6000 - Extension 1955, E-mail: roger.araujo{at}essalud.gob.pe
Back to top
Posted October 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru
Percy Soto-Becerra, Carlos Culquichicón, Yamilee Hurtado-Roca, Roger V. Araujo-Castillo
medRxiv 2020.10.06.20208066; doi: https://doi.org/10.1101/2020.10.06.20208066
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area